Nephros, Inc.

NEPH | $2.14 2.39% -0.96% 0

(0.0% 1d) (-1.8% 1m) (51.2% 1y) (0.0% 2d) (2.4% 3d) (1.9% 7d) (-95.23% volume)
Earnings Calendar: 2024-03-13
Market Cap: $ 22,564,457
http://www.nephros.com
Sec Filling | Patents | 25 employees

Nephros, Inc. is a medical device company, which engages in developing and selling liquid purification filters and an on-line mid dilution hemodiafiltration system. The company operates in two segments: Water Filtration and Renal Products. The Water Filtration segment includes both the medical device and commercial filtration product lines. The Renal Products segment comprises of SRP, which is focused on the development of medical device products for patients with renal disease, including a second-generation HDF system for the treatment of patients with ESRD. Its ultrafilters are used in dialysis centers for the removal of biological contaminants from water, bicarbonate concentrate and blood. The company was founded on April 3, 1997 and is headquartered in South Orange, NJ.

renal treatment

add to watch list Paper trade email alert is off

Press-releases

Nephros Announces Fourth Quarter and Fiscal Year 2023 Financial Results
Published: 2024-03-07 (Crawled : 21:00) - globenewswire.com
NEPH | $2.14 2.39% -0.96% 0

Health Technology

| -29.14% | O: -2.98% H: 2.05% C: -7.85%
year financial results

Nephros Schedules Conference Call for Fourth Quarter and Fiscal Year 2023 Financial Results
Published: 2024-02-29 (Crawled : 22:00) - globenewswire.com
NEPH | $2.14 2.39% -0.96% 0

Health Technology

| -32.28% | O: 0.47% H: 2.78% C: -2.68%
conference year financial results

Rezolute Expands Leadership Team with Appointment of Daron Evans, MS, MBA, as Chief Financial Officer
Published: 2024-01-24 (Crawled : 13:00) - globenewswire.com
RZLT 4 | $2.86 -19.21% -23.78% 0

Technology Services

| 180.39% | O: 2.94% H: 4.76% C: 3.33%
NEPH | $2.14 2.39% -0.96% 0

Health Technology

| -39.38% | O: 0.0% H: 3.12% C: 0.57%
financial

Nephros Announces Results for Quarter Ended September 30, 2023
Published: 2023-11-08 (Crawled : 21:00) - globenewswire.com
NEPH | $2.14 2.39% -0.96% 0

Health Technology

| 6.63% | O: -8.2% H: 6.11% C: 6.11%
results

Nephros Hires Judy Krandel as Chief Financial Officer
Published: 2023-11-01 (Crawled : 12:00) - globenewswire.com
FNCTF | News | $11.16 1.13% -20.84% 0

Communications

| -8.15% | O: -1.44% H: 0.0% C: -1.88%
XYF | News | $3.8825 -0.45% 0

Finance

| -3.48% | O: -1.46% H: 1.48% C: -0.29%
NEPH | $2.14 2.39% -0.96% 0

Health Technology

| 29.7% | O: -3.02% H: 7.49% C: 6.89%
financial

Nephros Schedules Third Quarter 2023 Financial Results Conference Call
Published: 2023-10-25 (Crawled : 12:00) - globenewswire.com
NEPH | $2.14 2.39% -0.96% 0

Health Technology

| 29.7% | O: 4.85% H: 0.0% C: -7.4%
conference financial results

Nephros Announces Results for Quarter Ended June 30, 2023
Published: 2023-08-09 (Crawled : 20:00) - globenewswire.com
NEPH | $2.14 2.39% -0.96% 0

Health Technology

| 52.86% | O: 5.86% H: 11.34% C: 1.89%
results

Nephros Schedules Second Quarter 2023 Financial Results Conference Call
Published: 2023-07-26 (Crawled : 12:00) - globenewswire.com
NEPH | $2.14 2.39% -0.96% 0

Health Technology

| 58.52% | O: 0.73% H: 4.42% C: 0.74%
conference financial results

Nephros Announces Results for Quarter Ended March 31, 2023
Published: 2023-05-10 (Crawled : 20:00) - globenewswire.com
NEPH | $2.14 2.39% -0.96% 0

Health Technology

| 46.58% | O: 6.16% H: 0.0% C: -6.65%
results

Nephros Announces CEO Retirement and Succession Plan
Published: 2023-05-08 (Crawled : 12:00) - globenewswire.com
NEPH | $2.14 2.39% -0.96% 0

Health Technology

| 48.61% | O: 2.08% H: 6.8% C: 1.36%
ceo

See all

Last 15 days Sec forms

File Id	Form	Published Date	Transaction Date	Direction	Code	Amount Transacted	Owned Amount
0001048462-24-000011	4	2024-03-14	2024-03-13	Buy	J	91463	98463
0001048462-24-000011	4	2024-03-14	2024-03-12	Buy	P	7000	7000